Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease

The objective of this study was to evaluate the impact of palivizumab prophylaxis on respiratory syncytial virus (RSV) hospitalizations among children with hemodynamically significant congenital heart disease (CHD). In 2003, the American Academy of Pediatrics (AAP) revised the bronchiolitis policy s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ruey-Kang R., Chen, Alex Y.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807022/
https://www.ncbi.nlm.nih.gov/pubmed/19915892
http://dx.doi.org/10.1007/s00246-009-9577-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807022/
https://www.ncbi.nlm.nih.gov/pubmed/19915892
http://dx.doi.org/10.1007/s00246-009-9577-0

Ejemplares similares